P1066: PEMBROLIZUMAB MONOTHERAPY AS A FIRST THERAPY FOR HODGKIN LYMPHOMA IS DELIVERABLE IN OLDER OR ABVD INELIGIBLE PATIENTS, DOES NOT PRECLUDE SUBSEQUENT THERAPY, AND PROVIDES ADE...

por Dickinson, Michael, Berkahn, Leanne, Trotman, Judith, Butler, Jason, Neeson, Paul, Bressel, Matthias, Minson, Adrian
Publicado 2023

GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (...

por Conduit, Ciara, Mak, Blossom, Qu, Wenjia, Lulio, Juliana Di, Burder, Ronan, Bressel, Matthias, Cusick, Thomas, Dhillon, Haryana M., Lourenço, Richard De Abreu, Underhill, Craig, Torres, Javier, Crumbaker, Megan, Honeyball, Florian, Linton, Anthony, Allen, Ray, Davis, Ian D., Clark, Susan J., Horvath, Lisa G., Mahon, Kate L.
Publicado 2022